Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Cost and Outcomes Information Should Be Part of Shared Decision Making

Cost and Outcomes Information Should Be Part of Shared Decision Making Letters protection during Clostridium difficile infection. Cell Rep. 2016;16(2):432-443. Davido et al mention several concerns. First, they point out doi:10.1016/j.celrep.2016.06.007 that the study period is 10 years and that there have been in- 3. Cowardin CA, Buonomo EL, Saleh MM, et al. The binary toxin CDT enhances terval changes to the Infectious Diseases Society of America Clostridium difficile virulence by suppressing protective colonic eosinophilia. (IDSA) guidelines during that time. They mention a second, re- Nat Microbiol. 2016;1(8):16108. doi:10.1038/nmicrobiol.2016.108 lated concern that we did not consider the influence of differ- 4. Cohen SH, Gerding DN, Johnson S, et al; Society for Healthcare ent difficile-directed antibiotics on our outcomes of interest. Epidemiology of America; Infectious Diseases Society of America. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by Readers should note that until recently, there was an emphasis the Society for Healthcare Epidemiology of America (SHEA) and the Infectious on reducing vancomycin usage because of concerns for vanco- Diseases Society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31(5): mycin-resistant Enterococci, a concern acknowledged in the 431-455. doi:10.1086/651706 4 5 2010 IDSA recommendations. The 2017 IDSA update favors 5. McDonald LC, Gerding DN, Johnson S, et al. Clinical practice http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Surgery American Medical Association

Cost and Outcomes Information Should Be Part of Shared Decision Making

Weeks, William B.; Weinstein, James N.
JAMA Surgery , Volume 154 (5) – May 13, 2019
Download PDF
2 pages

Loading next page...
 
/lp/american-medical-association/cost-and-outcomes-information-should-be-part-of-shared-decision-making-xzGuT5DH8X

References (5)

Publisher
American Medical Association
Copyright
Copyright 2019 American Medical Association. All Rights Reserved.
ISSN
2168-6254
eISSN
2168-6262
DOI
10.1001/jamasurg.2018.5581
Publisher site
See Article on Publisher Site

Abstract

Letters protection during Clostridium difficile infection. Cell Rep. 2016;16(2):432-443. Davido et al mention several concerns. First, they point out doi:10.1016/j.celrep.2016.06.007 that the study period is 10 years and that there have been in- 3. Cowardin CA, Buonomo EL, Saleh MM, et al. The binary toxin CDT enhances terval changes to the Infectious Diseases Society of America Clostridium difficile virulence by suppressing protective colonic eosinophilia. (IDSA) guidelines during that time. They mention a second, re- Nat Microbiol. 2016;1(8):16108. doi:10.1038/nmicrobiol.2016.108 lated concern that we did not consider the influence of differ- 4. Cohen SH, Gerding DN, Johnson S, et al; Society for Healthcare ent difficile-directed antibiotics on our outcomes of interest. Epidemiology of America; Infectious Diseases Society of America. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by Readers should note that until recently, there was an emphasis the Society for Healthcare Epidemiology of America (SHEA) and the Infectious on reducing vancomycin usage because of concerns for vanco- Diseases Society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31(5): mycin-resistant Enterococci, a concern acknowledged in the 431-455. doi:10.1086/651706 4 5 2010 IDSA recommendations. The 2017 IDSA update favors 5. McDonald LC, Gerding DN, Johnson S, et al. Clinical practice

Journal

JAMA Surgery – American Medical Association

Published: May 13, 2019

There are no references for this article.